Lord, Abbett & Co
RVMD icon

Lord, Abbett & Co’s Revolution Medicines RVMD Stock Holding History

Lord, Abbett & Co’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148M Buy
789,241
+655,008
+488% +$95.7M 0.42% 59
2026
Q1 		$13.1M Sell
134,233
-265,251
-66% -$26.8M 0.04% 327
2025
Q4 		$31.8M Buy
+399,484
New +$26.2M 0.1% 204
2025
Q2 		– Sell
-367,630
Closed -$13M – 572
2025
Q1 		$13M Sell
367,630
-1,611,090
-81% -$65.4M 0.05% 336
2024
Q4 		$86.5M Buy
1,978,720
+146,699
+8% +$7.4M 0.27% 101
2024
Q3 		$83.1M Buy
+1,832,021
New +$79.8M 0.26% 113
2020
Q3 		– Sell
-97,987
Closed -$3.09M – 675
2020
Q2 		$3.09M Sell
97,987
-52,807
-35% -$1.66M 0.01% 603
2020
Q1 		$3.3M Buy
+150,794
New +$4.17M 0.01% 576

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Lord, Abbett & Co's RVMD Position: Q2 2026 in Review

Lord, Abbett & Co increased its Revolution Medicines (RVMD) stake by 488% in Q2 2026, buying an estimated $95.7M and bringing the position to 789,241 shares worth $148M. The position accounts for 0.42% of the portfolio, ranked #59.

Lord, Abbett & Co first reported a position in RVMD in Q1 2020 and has held it in 8 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Lord, Abbett & Co held 789,241 shares of Revolution Medicines worth $148M as of Q2 2026.
  • Lord, Abbett & Co bought 655,008 Revolution Medicines shares in Q2 2026, an estimated $95.7M.
  • Revolution Medicines made up 0.42% of Lord, Abbett & Co's portfolio in Q2 2026, its #59 holding.
  • Lord, Abbett & Co first reported a position in Revolution Medicines in Q1 2020 and has held it in 8 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.